Viropin's Mission is to pioneer a future where infectious diseases are anticipated and neutralised before they threaten humanity.
The world is on the verge of a microbial apocalypse with the rise in drug-resistant microbes.
Viropin has a 3-prong approach to disease control:
1. Surveillance via proprietary AI tech.
2. Diagnostics via VariantVault, a cutting-edge microbe library.
3. Treatment of drug-resistant microbes with proprietary sterilants, decolonizers and anti-viral products.
Company Details
- Employees
- 4
- Founded
- 2024
- Address
- 8 Stafford St, Dunedin,otago 9016,new Zealand
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.viropin.com
- Keywords
- Dunedin.
- HQ
- Dunedin, Otago
Viropin Pharmaceutical Questions
Viropin Pharmaceutical's website is https://www.viropin.com
Viropin Pharmaceutical's LinkedIn profile is https://nz.linkedin.com/company/viropin-pharmaceutical
Viropin Pharmaceutical has
4 employees.
View email and phone details for 4
employees at Viropin Pharmaceutical.
Viropin Pharmaceutical's industry is
Biotechnology Research
Viropin Pharmaceutical's top competitors are
Norvita,
Scarab Group,
Topline Carpenters Ltd,
Instatdata,
Nudie,
Ikimi,
Maurice Wilkins Centre,
Zestt Wellness,
Tacct Global,
Talent Therapeutics.
Viropin Pharmaceutical's categories are Biotechnology Research
Viropin Pharmaceutical's founding year is 2024
